Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-01-01
2021-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Kidney Injury in Patients With CoVID-19
NCT04872764
Acute Kidney Injury in Critical COVID-19: Outcomes and Risks
NCT07089693
Acute Kidney Injury in Coronavirus Disease-19 (COVID-19) Patients Admitted to the Intensive Care Unit (ICU)
NCT04997915
Acute Kidney Injury Risk in COVID-19
NCT04874779
Acute Kidney Injury and Acute Kidney Disease in COVID-19
NCT04353583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE
COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE
ACUTE KIDNEY INJURY
KDIGO LEVELS
COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE
COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE
ACUTE KIDNEY INJURY
KDIGO LEVELS
COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.
COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.
ACUTE KIDNEY INJURY
KDIGO LEVELS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACUTE KIDNEY INJURY
KDIGO LEVELS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients in ICU
Exclusion Criteria
* who have received dialysis treatment before
* who are under 18 years of age
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli Derince Education and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aki̇f Şahi̇n
md
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
akif şahin
Role: PRINCIPAL_INVESTIGATOR
kocaeli derh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akif Şahin
Kocaeli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.
Aleebrahim-Dehkordi E, Reyhanian A, Saberianpour Sh, Hasanpour-Dehkordi A. Acute kidney injury in COVID-19; a review on current knowledge. J Nephropathol. 2020;9:e31. doi: 10.34172/jnp.2020.31
Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kocaeli derh
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.